KRD (CARFILZOMIB PLUS LENALIDOMIDE PLUS DEXAMETHASONE) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN CAMPANIA REGION: A ONE-YEAR SURVEY

被引：0
|
作者：
Palmieri, S. [1 ]
Rocco, S. [1 ]
Migliaccio, I. [1 ]
Cerchione, C. [2 ]
Catalano, L. [2 ]
Ferrara, K. [2 ]
Peluso, I. [2 ]
Monaco, G. [1 ]
Farina, G. [3 ]
Gagliardi, A. [4 ]
Barone, M. [5 ]
Esposito, D. [6 ]
Amico, V. [7 ]
Arcamone, M. [8 ]
Fontana, R. [9 ]
Sica, A. [10 ]
Pane, F. [2 ]
Ferrara, F. [1 ]
机构：
[1] AORN A Cardarelli, Ematol Unita TMO, Naples, Italy
[2] AUOP Federico II, Ematol, Naples, Italy
[3] AORN S Anna & S Sebastiano, UOC Oncoematol, Naples, Italy
[4] ASL Na1 Ctr, Osped Ascalesi, UOC Ematol, Naples, Italy
[5] PO A Tortora, UO Ematol Oncol, Naples, Italy
[6] Osped San Giuseppe Moscati, ASL CE, UOC Ematol, Statte, TA, Italy
[7] AORN G Rummo, DH Ematol, Benevento, Italy
[8] Fdn G Pascale IRCCS, UOSC Ematol Oncol, Naples, Italy
[9] AOU Ruggi dAragona, Ematol, Salerno, Italy
[10] AOU Vanvitelli, Oncol Med & Ematol, Naples, Italy
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P188
引用
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [31] Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma
    Jasielec, Jagoda K.
    Kubicki, Tadeusz
    Raje, Noopur
    Vij, Ravi
    Reece, Donna
    Berdeja, Jesus
    Derman, Benjamin A.
    Rosenbaum, Cara A.
    Richardson, Paul
    Gurbuxani, Sandeep
    Major, Sarah
    Wolfe, Brittany
    Stefka, Andrew T.
    Stephens, Leonor
    Tinari, Kathryn M.
    Hycner, Tyler
    Rojek, Alexandra E.
    Dytfeld, Dominik
    Griffith, Kent A.
    Zimmerman, Todd M.
    Jakubowiak, Andrzej J.
    BLOOD, 2020, 136 (22) : 2513 - 2523
  • [32] Erratum to: Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
    Shinsuke Iida
    Takaaki Chou
    Shinichiro Okamoto
    Hirokazu Nagai
    Kiyohiko Hatake
    Hirokazu Murakami
    Toshiyuki Takagi
    Kazuyuki Shimizu
    Henry Lau
    Kenichi Takeshita
    Masaaki Takatoku
    Tomomitsu Hotta
    International Journal of Hematology, 2010, 92 (1) : 127 - 128
  • [33] The Impact of Cytogenetics on the Outcomes of Treatment with Lenalidomide Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma
    Bahlis, Nizar J.
    Song, Kevin W.
    Fu, Tommy
    Roland, Birgitte J.
    Chang, Hong
    Horsman, Doug
    Mansoor, Adnan
    Chen, Christine
    Masih-Khan, Esther
    Trieu, Young
    Bruyere, Helene
    Stewart, Douglas A.
    Reece, Donna E.
    BLOOD, 2008, 112 (11) : 610 - 610
  • [34] Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America
    Weber, Donna M.
    Chen, Christine
    Niesvizky, Ruben
    Wang, Michael
    Belch, Andrew
    Stadtmauer, Edward A.
    Siegel, David
    Borrello, Ivan
    Rajkumar, S. Vincent
    Chanan-Khan, Asher Alban
    Lonial, Sagar
    Yu, Zhinuan
    Patin, John
    Olesnyckyj, Marta
    Zeldis, Jerome B.
    Knight, Robert D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) : 2133 - 2142
  • [35] Weekly carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed or refractory multiple myeloma (RRMM): A phase 1b study.
    Biran, Noa
    Siegel, David Samuel DiCapua
    Berdeja, Jesus G.
    Raje, Noopur S.
    Cornell, Robert F.
    Alsina, Melissa
    Kovacsovics, Tibor
    Fang, Belle
    Kimball, Amy
    Landgren, Carl Ola
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [36] Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma
    Jakubowiak, Andrzej J.
    Jasielec, Jagoda K.
    Rosenbaum, Cara A.
    Cole, Craig E.
    Chari, Ajai
    Mikhael, Joseph
    Nam, Jennifer
    McIver, Amanda
    Severson, Erica
    Stephens, Leonor A.
    Tinari, Kathryn
    Rosebeck, Shaun
    Zimmerman, Todd M.
    Hycner, Tyler
    Turowski, Agata
    Karrison, Theodore
    Zonder, Jeffrey A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (04) : 549 - 560
  • [37] Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma
    Richardson, P. G.
    Trudel, S.
    Popat, R.
    Mateos, M-, V
    Vangsted, A. J.
    Ramasamy, K.
    Martinez-Lopez, J.
    Quach, H.
    Orlowski, R. Z.
    Arnao, M.
    Lonial, S.
    Karanes, C.
    Pawlyn, C.
    Kim, K.
    Oriol, A.
    Berdeja, J. G.
    Rodriguez Otero, P.
    Casas-Aviles, I
    Spirli, A.
    Poon, J.
    Li, S.
    Gong, J.
    Wong, L.
    Lamba, M.
    Pierce, D. W.
    Amatangelo, M.
    Peluso, T.
    Maciag, P.
    Katz, J.
    Pourdehnad, Michael
    Bahlis, Nizar J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (11) : 1009 - 1022
  • [38] Phase 2 Study of Venetoclax Plus Carfilzomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma
    Costa, Luciano J.
    Stadtmauer, Edward A.
    Morgan, Gareth
    Monohan, Gregory
    Kovacsovics, Tibor
    Burwick, Nicholas
    Jakubowiak, Andrzej
    Kaufman, Jonathan L.
    Mobasher, Mehrdad
    Freise, Kevin J.
    Ross, Jeremy A.
    Pesko, John
    Munasinghe, Wijith
    Gudipati, Saketh
    Mudd, Sarah
    Bueno, Orlando
    Kumar, Shaji K.
    BLOOD, 2018, 132
  • [39] Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma
    Costa, Luciano J.
    Davies, Faith E.
    Monohan, Gregory P.
    Kovacsovics, Tibor
    Burwick, Nicholas
    Jakubowiak, Andrzej
    Kaufman, Jonathan L.
    Hong, Wan-Jen
    Dail, Monique
    Salem, Ahmed Hamed
    Yang, Xiaoqing
    Masud, Abdullah A.
    Munasinghe, Wijith
    Ross, Jeremy A.
    Bueno, Orlando F.
    Kumar, Shaji K.
    Stadtmauer, Edward A.
    BLOOD ADVANCES, 2021, 5 (19) : 3748 - 3759
  • [40] Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study
    Jakubowiak, Andrzej J.
    Richardson, Paul G.
    Zimmerman, Todd
    Alsina, Melissa
    Kaufman, Jonathan L.
    Kandarpa, Malathi
    Kraftson, Stephanie
    Ross, Charles W.
    Harvey, Colleen
    Hideshima, Teru
    Sportelli, Peter
    Poradosu, Enrique
    Gardner, Lesa
    Giusti, Kathy
    Anderson, Kenneth C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (04) : 472 - 480
12345